These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35163224)

  • 1. Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
    Loginov VI; Pronina IV; Filippova EA; Burdennyy AM; Lukina SS; Kazubskaya TP; Uroshlev LA; Fridman MV; Brovkina OI; Apanovich NV; Karpukhin AV; Stilidi IS; Kushlinskii NE; Dmitriev AA; Braga EA
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel miRNAs as Potential Regulators of PD-1/PD-L1 Immune Checkpoint, and Prognostic Value of MIR9-1 and MIR124-2 Methylation in Ovarian Cancer].
    Kushlinskii NE; Loginov VI; Utkin DO; Filippova EA; Burdennyy AM; Korotkova EA; Pronina IV; Lukina SS; Smirnova AV; Gershtein ES; Braga EA
    Mol Biol (Mosk); 2020; 54(6):990-996. PubMed ID: 33276362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Methylation of a Group of microRNA Genes in the Pathogenesis of Metastatic Renal Cell Carcinoma.
    Ivanova NA; Burdennyi AM; Lukina SS; Filippova EA; Pronina IV; Karpukhin AV; Matveev VB; Kazubskaya TP; Loginov VI; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2023 Jun; 175(2):249-253. PubMed ID: 37466853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Marker System for Early Diagnosis of Breast Cancer.
    Burdennyy AM; Filippova EA; Khodyrev DS; Pronina IV; Lukina SS; Ivanova NA; Kazubskaya TP; Loginov VI; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):57-62. PubMed ID: 34791555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Methylation of 21 MicroRNA Genes in Breast Cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.
    Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Karpukhin AV; Khodyrev DS; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):67-71. PubMed ID: 34792716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis].
    Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Kazubskaya TP; Kushlinsky DN; Ermilova VD; Rykov SV; Khodyrev DS; Braga EA
    Mol Biol (Mosk); 2018; 52(5):801-809. PubMed ID: 30363055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
    Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
    World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between the Levels of Methylation of microRNA Gene Sets in Primary Tumors and Metastases of Ovarian Cancer Patients.
    Lukina SS; Burdennyy AM; Filippova EA; Pronina IV; Ivanova NA; Kazubskaya TP; Kushlinskii DN; Utkin DO; Loginov VI; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2022 May; 173(1):87-91. PubMed ID: 35622253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems.
    Filippova EA; Loginov VI; Burdennyi AM; Braga EA; Pronina IV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Fridman MV; Khodyrev DS; Kushlinskii NE
    Bull Exp Biol Med; 2019 May; 167(1):79-83. PubMed ID: 31177462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of methylation of a group of miRNA genes in patients with ovarian cancer.].
    Kushlinskii NE; Utkin DO; Loginov VI; Filippova EA; Burdennyy AM; Kushlinsky DN; Pronina IV; Braga EA
    Klin Lab Diagn; 2020; 65(5):321-327. PubMed ID: 32298550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
    Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
    J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.
    Yu X; Zhang X; Bi T; Ding Y; Zhao J; Wang C; Jia T; Han D; Guo G; Wang B; Jiang J; Cui S
    Tumour Biol; 2013 Dec; 34(6):3501-8. PubMed ID: 23836287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of the Levels of microRNA Gene Methylation with the Level of Their Expression and Pathomorphological Characteristics of Breast Cancer.
    Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Braga EA; Burdennyi AM; Loginov VI
    Bull Exp Biol Med; 2021 Oct; 171(6):764-769. PubMed ID: 34705180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation.
    Parvathareddy SK; Siraj AK; Al-Badawi IA; Tulbah A; Al-Dayel F; Al-Kuraya KS
    Sci Rep; 2021 Feb; 11(1):3750. PubMed ID: 33580098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect.
    Burdennyy AM; Filippova EA; Ivanova NA; Lukina SS; Pronina IV; Loginov VI; Fridman MV; Kazubskaya TP; Utkin DO; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2021 Jul; 171(3):370-374. PubMed ID: 34292442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
    Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
    Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.